Pre-Market Stock Notes (DEC 20, 2006)
(ABTL) Autobytel.com settles with Dealix & will receive $20 million in settlement.(ADBE) Adobe positive by Cramer on MAD MONEY.(AIR) AAR $0.33 EPS vs $0.32e; wins Southwest Air pact.(ALOY) Alloy pays $10.50 per share to retire shares from large inside on…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
(ABTL) Autobytel.com settles with Dealix & will receive $20 million in settlement.
(ADBE) Adobe positive by Cramer on MAD MONEY.
(AIR) AAR $0.33 EPS vs $0.32e; wins Southwest Air pact.
(ALOY) Alloy pays $10.50 per share to retire shares from large inside on BOD.
(ALTU) Altus Pharma enters into strategic collaboration with Genentech; will get $15M investment.
(AMT) Amer Tower resuming is $390+M remaining share buyback plan.
(ARTE) Artes Medical IPO priced at $6.00 for 4.6M shares.
(DELL) Dell’s CFO is leaving; replaced by old AMR CFO Carty.
(DRI) Darden $0.41 EPS vs $0.40e.
(FDO) Family Dollar preliminary EPS posted as $0.36 vs $0.36e.
(FDX) FedEx telegraphs earnings in-line, but that is before pilot costs from cointract; guidance looks light for the following quarter; stock indicated down $3 to $5 pre-market.
(FPL) FPL pays almost $1B to buy Point Beach Nuke Power.
(HYDL) Hydril slight boost to current guidance.
(INWK) InnerWorkings positive by Cramer on MAD MONEY.
(JBX) Jack in the Box tender results were 2.3+ million shares at average of $61.00.
(KMX) CarMax $0.42 EPS vs $0.26e; unsure if comparable.
(KOSN) Kosan Biosciences licenses motilin agonist program to Pfizer.
(LNT) Alliant Energyraised 2007 guidance; reaffirmed 2008 guidance; hikes dividend.
(MXIM) Maxim Integrated CEO is retiring for health reasons.
(NBIX) Neurocrine initiates phase II trial with CRF1 Antagonist with GSK.
(NFLD) Northfield Labs traded lower by 50% after poor results on blood substitute product.
(PALM) Palm fell another 2% after disappointing outlook again after beating lowered estimates.
(PAY) Verifone positive by Cramer on MAD MONEY.
(PKE) ParK Electrochemical $0.47 EPS vs $0.47e.
(QLTI) QLT signs research collaboration with Wilmer Eye of Johns Hopkins.
(RBAK) Redback in takeover deal with Ericsson at $25.00 per share.
(SOLF) SolarFun Power 12M share IPO priced at $12.50 from Goldman Sachs.
(ZGEN) Zymogenetics started Phase II rheumatoid arthritis with Serono.
Contact [email protected] for any questions or corrections.
Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.
McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.
His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.
A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.
TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.
McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.